The Attractions Of Conducting Clinical TrialsJuly 2010 | Industry Trend Analysis
Kenya, as with other markets in the region, can offer drugmakers numerous benefits including access to large, treatment-naïve populations as a result of underdeveloped healthcare systems. BMI notes that this is vital in clinical trials as it reduces data variability. Furthermore, Africa has the world's highest population of HIV-positive patients and is a hub for communicable diseases as a result of its underdeveloped infrastructure. With the vaccine industry experiencing rejuvenation through globally-funded alliances, providing cheaper immunisation programmes for developing countries, conducting clinical trials in selected sub-populations has become increasingly important.
To read the full article, please choose one of the following options: